CN1154497C - 治疗肝脏肿瘤的方法和其中所用的药学组合物 - Google Patents

治疗肝脏肿瘤的方法和其中所用的药学组合物 Download PDF

Info

Publication number
CN1154497C
CN1154497C CNB988067609A CN98806760A CN1154497C CN 1154497 C CN1154497 C CN 1154497C CN B988067609 A CNB988067609 A CN B988067609A CN 98806760 A CN98806760 A CN 98806760A CN 1154497 C CN1154497 C CN 1154497C
Authority
CN
China
Prior art keywords
vitamin
purposes
medicine
cancer
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB988067609A
Other languages
English (en)
Chinese (zh)
Other versions
CN1261800A (zh
Inventor
��ά����ɭ��Ī��˹
戴维·劳森·莫利斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MRC HOLDING CO Ltd
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Publication of CN1261800A publication Critical patent/CN1261800A/zh
Application granted granted Critical
Publication of CN1154497C publication Critical patent/CN1154497C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CNB988067609A 1997-06-10 1998-06-10 治疗肝脏肿瘤的方法和其中所用的药学组合物 Expired - Fee Related CN1154497C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO7270A AUPO727097A0 (en) 1997-06-10 1997-06-10 Method of treatment of hepatoma and pharmaceutical compositions for use therein
AUPO7270 1997-06-10

Publications (2)

Publication Number Publication Date
CN1261800A CN1261800A (zh) 2000-08-02
CN1154497C true CN1154497C (zh) 2004-06-23

Family

ID=3801562

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988067609A Expired - Fee Related CN1154497C (zh) 1997-06-10 1998-06-10 治疗肝脏肿瘤的方法和其中所用的药学组合物

Country Status (8)

Country Link
US (1) US6486144B1 (enExample)
EP (1) EP1003523A4 (enExample)
JP (1) JP2002504100A (enExample)
KR (1) KR100382219B1 (enExample)
CN (1) CN1154497C (enExample)
AU (1) AUPO727097A0 (enExample)
WO (1) WO1998056387A1 (enExample)
ZA (1) ZA985028B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
AU765846B2 (en) * 1998-05-04 2003-10-02 Mrc Holdings Pty Limited Pharmaceutical composition
AUPP332898A0 (en) * 1998-05-04 1998-05-28 Unisearch Limited Pharmaceutical composition
US20030031670A1 (en) * 1999-11-08 2003-02-13 Jack R. Wands Diagnosis and treatment of malignant neoplasms
WO2001034199A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
DE10032587A1 (de) * 2000-07-05 2002-01-17 Bayer Ag 4-Alkoxy-cyclohexan-1-amino-carbonsäureester und Verfahren zu ihrer Herstellung
AU781168B2 (en) 2001-01-26 2005-05-12 Pfizer Products Inc. Method of treating certain cancers using an estrogen agonist/antagonist
US20050038022A1 (en) * 2001-03-26 2005-02-17 Unisearch Limited Method for treatment of cancer and compositions for use therein
JP2004026811A (ja) * 2002-04-30 2004-01-29 Kiyoshi Hashizume ビタミンｄ３誘導体を含有する抗癌作用を増強させるための薬剤
AU2002330482A1 (en) 2002-09-04 2004-03-29 Perseus Proteomics Inc. Method of diagnosing cancer by detecting gpc3
WO2004047673A2 (en) * 2002-11-21 2004-06-10 Novacea, Inc. Treatment of liver disease with active vitamin d compounds
WO2005027922A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. 2-alkylidene-19-nor-vitamin d derivatives for the treatment of hypogonadism or andropause
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
CA2539361A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist
WO2005027918A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a cyclooxgenase-2 inhibitor
WO2005027928A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. 2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
JP4248544B2 (ja) * 2005-12-19 2009-04-02 株式会社椿本チエイン 伝動装置用可動ガイド
AU2010282731C1 (en) * 2009-08-14 2016-04-21 Berg Llc Vitamin D3 and analogs thereof for treating alopecia
EP2988752A4 (en) 2013-04-24 2017-01-18 Salk Institute for Biological Studies Vitamin d receptor/smad genomic circuit gates fibrotic response
CN105451818A (zh) * 2013-06-05 2016-03-30 萨克生物研究学院 治疗涉及cxcl12活性的疾病的维生素d受体激动剂
JP2016124818A (ja) * 2014-12-26 2016-07-11 日本化薬株式会社 転移性肝癌治療薬及び転移性肝癌の治療方法
WO2016167977A1 (en) 2015-04-14 2016-10-20 Mayo Foundation For Medical Education And Research Methods and materials for delivering agents to liver tissue
WO2019023149A1 (en) 2017-07-24 2019-01-31 Salk Institute For Biological Studies USE OF BROMODOMAIN-CONTAINING PROTEIN-9 ANTAGONISTS IN ASSOCIATION WITH VITAMIN D RECEPTOR AGONISTS IN THE TREATMENT OF DIABETES
CN116059364B (zh) * 2021-11-04 2025-07-11 上海健康医学院 Dhcr7下调剂在减弱酒精诱导的肝脏肿瘤中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0296800B1 (en) * 1987-06-23 1991-10-16 Yamanouchi Pharmaceutical Co. Ltd. Vitamin d3 derivatives
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
US5798345A (en) 1990-09-21 1998-08-25 Bone Care International, Inc. Method of inhibiting the hyperproliferation of malignant cells
DK0707566T3 (da) * 1993-07-09 2000-09-04 Theramex Hidtil ukendte strukturelle analoger til vitamin D
US5856189A (en) * 1997-01-07 1999-01-05 The Regents Of The University Of Michigan Cell culture model for drug bioavailability

Also Published As

Publication number Publication date
ZA985028B (en) 1999-01-25
AUPO727097A0 (en) 1997-07-03
US6486144B1 (en) 2002-11-26
CN1261800A (zh) 2000-08-02
KR100382219B1 (ko) 2003-04-26
HK1030144A1 (en) 2001-04-27
JP2002504100A (ja) 2002-02-05
EP1003523A4 (en) 2001-08-22
EP1003523A1 (en) 2000-05-31
WO1998056387A1 (en) 1998-12-17
KR20010013651A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
CN1154497C (zh) 治疗肝脏肿瘤的方法和其中所用的药学组合物
EP1993559B1 (en) Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
GERTNER et al. Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system
CN1554351A (zh) 包含活性维生素d化合物的药物组合制剂及其应用
KR20060054198A (ko) 활성 비타민 ｄ를 포함하는 약제조성물
AU2010212456B2 (en) Formulas comprising calcium, magnesium, zinc, and vitamin D3, for the prevention and amelioration of osteoporosis
Llach et al. The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism
Collins et al. Tumor imaging via indium 111–labeled DTPA–adenosylcobalamin
US20060177374A1 (en) Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments
Bacchini et al. ‘Pulse Oral’versus Intravenous Calcitriol Therapy in Chronic Hemodialysis Patients: A Prospective and Randomized Study
US20070218126A1 (en) Compositions and Methods for Reducing Inflammation and Pain Associated with Acidosis
Gómez et al. Calcium citrate and vitamin D in the treatment of osteoporosis
Shirvani et al. Man of steel syndrome: silicone and mineral oil injections with associated hypercalcemia, hypophosphatemia, and proximal muscle weakness
HK1044117A1 (en) Pharmaceutical composition
Wieder et al. Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies
Verburg et al. Molecular nuclear therapies for thyroid carcinoma
HK1030144B (en) Method for treatment of liver tumours and pharmaceutical compositions for use therein
Rezende et al. Severe hypercalcemia caused by repeated mineral oil injections: a case report
AU735676B2 (en) Method of treatment of liver tumours and pharmaceutical compositions for use therein
Luo et al. False-positive uptake of 131I from basal cell papilloma in a patient with metastatic papillary thyroid Cancer
CN102210696A (zh) 一种含唑来膦酸的药物组合
WO2013014654A2 (en) Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
JP2001511818A (ja) ９，１０−セココレスタ−５，７，１０（１９）−トリエン−１，３−ジオール、即ちアルファカルシドールの使用
CZ2016821A3 (cs) Kombinace pro radionuklidovou terapii pro použití jako léčivo
Tan et al. A CASE OF A HUNGRY BONE

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: MRC HOLDING CO., LTD.

Free format text: FORMER OWNER: UNISEARCH LTD.

Effective date: 20011030

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20011030

Applicant after: MRC Holding Co., Ltd.

Applicant before: Unisearch Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1030144

Country of ref document: HK

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee